Quetiapine Fumarate
- Product NDC
- 52817-163
- 11-digit product format
- 528170163
- Labeler code
- 52817
- Product ID
- 52817-163_b67989d1-c748-3488-e053-2995a90a6a6a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Quetiapine Fumarate
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- TruPharma, LLC
- Application
- ANDA206260
- Marketing category
- ANDA
- Marketing start
- 2017-05-10
- Marketing end
- 0000-00-00
- Substance
- QUETIAPINE FUMARATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 52817-163-60 | 52817016360 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (52817-163-60) | 2017-05-10 | 0000-00-00 | No | No | Current |